Weight Loss

• Higher doses of Zepbound to be offered on Eli Lilly website

  The company said the 12.5 milligrams and 15 mg doses of the drug will be available for US$499 per month on the website with shipments to self-paying patients.

  Consumer

  Jun 16
  
• Canadian scientist awarded for discovering hormone used in Ozempic

  Dr. Daniel Drucker shares the US$3 million prize with four colleagues in the U.S. and Denmark for discovering the GLP-1 hormone that's used in medications like Ozempic.

  Canada

  Apr 7
  
• Advertisement
• Does fizzy water help you lose weight? Here’s what the research says

  A study published in BMJ Nutrition, Prevention & Health suggests the CO2 in carbonated water might help with weight loss by boosting how red blood cells process glucose.

  Health

  Jan 23
• Advertisement
• Canadian spa didn’t deliver on promise to improve man’s love handles, court rules

  In his decision, the Nova Scotia adjudicator wrote that after reviewing the before and after photos, he was "unable to see any visible difference" to the man's love handles.

  Canada

  Jan 16
• Weight-loss medication helps mom manage her obesity. Quebec won’t pay for any of it

  Quebec's health insurance board currently doesn't cover Ozempic and similar weight-loss medication unless they are prescribed for patients who are diagnosed with diabetes.

  Canada

  Oct 24, 2024
• Eli Lilly’s weight-loss drug cuts diabetes risk, long-term study finds

  The three-year study of tirzepatide found adults with prediabetes and obesity or overweight taking the drug weekly saw the risk of progression to diabetes lower by 94 per cent.

  Health

  Aug 20, 2024
• What is Zepbound? Could the weight-loss drug work better than Ozempic?

  Zepbound has been approved in the U.S. for weight loss, and studies show it could be the best-performing obesity drug to date.

  Health

  Nov 10, 2023
• What is intermittent fasting? A look at its potential health benefits

  Intermittent fasting, which is time-restricted eating, is among a growing number of weight loss regimes that have risen in popularity.

  Health

  Oct 28, 2023
• Advertisement
• The EU Ozempic probe is expanding. What you should know

  The agency began its review after Iceland's health regulator flagged reports of patients thinking about suicide and one case of thoughts of self harm after use of Novo's drugs.

  Health

  Jul 11, 2023
• Advertisement
• Ozempic, Saxenda drugs under EU probe over reports of suicidal thoughts

  The review has been announced weeks after the regulator raised a thyroid cancer safety signal on several of Novo's products that contain semaglutide.

  Health

  Jul 10, 2023